PATIENTS SAY “NO” TO UNJUSTIFIABLE NEW REGULATIONS THAT WILL OBSTRUCT THE ENTRY OF NEW MEDICINES TO CANADA
FOR IMMEDIATE RELEASE:
April 8, 2019, (Toronto, Ontario) Two major Canadian patient organizations have appealed directly to Prime Minister Trudeau in an open letter calling for a moratorium on planned changes to the Patented Medicines Regulations which could harm patient access to new life-saving drugs.
In the letter which is available at www.raredisorders.ca, Dr. Durhane Wong-Rieger, President and CEO of the Canadian Organization for Rare Disorders (CORD) and Martine Elias, Executive Director, Myeloma Canada express urgent concerns over how the new regulations will impact the entry of new medicines into Canada. Dr. Wong-Riegerand Ms. Eliasserve as patient members on a Steering Committee that is studying the proposed Patented Medicines Prices Review Board (PMPRB) regulatory changes.
“As patient members appointed to the PMPRB Steering Committee on Guidelines Modernization, our responsibility is to ensure the needs of the millions of Canadian patients are adequately reflected in the proposed regulatory changes,” said Dr. Wong-Rieger. “So far, there is no indication that the PMPRB is willing to listen and we appear to be crash test dummies in a vehicle on a pre-set course to go over a cliff.”
“We all want to have access to medicines at affordable prices,” added Ms. Elias. “However, these proposed changes by the PMPRB will mean that many new therapies will not be available in Canada. It will be unethical, unjustifiable, and unfair but nevertheless inevitable that Canadian patients will be denied breakthrough, lifesaving, and even incrementally better medicines.”
The patient representatives urge the Prime Minister to exercise his leadership and instruct the PMPRB to undertake a proper consultation on the proposed changes before it’s too late, especially in light of new national Pharmacare initiatives. Dr. Wong-Rieger added that, “If done right, consultations on a new national Pharmacare program could lead to better access to affordable medicines that patients need to be well and, in many cases, survive.”
CONTACT
Durhane Wong-Rieger
Canadian Organization for Rare Disorders
(647) 801-5176
durhane@raredisorders.ca
The Canadian Organization for Rare Disorders Hereby Gives Notice of its Annual General Meeting: August 26, 2024 at 2:00 PM (EDT) via videoconference
CORD Annual General MeetingAugust 26, 2024 at 2:00 PM (EDT) via videoconference Dear CORD Members: The Canadian Organization for Rare Disorders gives notice of it's Annual General Meeting on August 26, 2024 at 2pm - 3pm (Eastern Time). All individual, affiliate and corporate members in good standing are invited participate. An eligible voter must be a representative of a voting member of CORD. Eligible voters may either vote at the upcoming Annual General Meeting videoconference or by proxy. Votes by proxy must be in must be returned to us by August 25, 2024. Ballots received after this date and time, duplicate votes and spoiled ballots will not be counted. To participate in the AGM teleconference, please register by August 25, 2024 Registration: https://bit.ly/4aM8IJL Once we have received your response, we will email you the teleconference details and any other necessary documents that will be required for the meeting. Thank you for your participation and if you have any questions, please let me know. Sincerely, Christine White CORD Secretary PROXY-2024Download
The Canadian Organization for Rare Disorders Hereby Gives Notice of its Annual General Meeting: August 26, 2024 at 2:00 PM (EDT) via videoconference
CORD Annual General MeetingAugust 26, 2024 at 2:00 PM (EDT) via videoconference Dear CORD Members: The Canadian Organization for Rare Disorders gives notice of it's Annual General Meeting on August 26, 2024 at 2pm - 3pm (Eastern Time). All individual, affiliate and corporate members in good standing are invited participate. An eligible voter must be a representative of a voting member of CORD. Eligible voters may either vote at the upcoming Annual General Meeting videoconference or by proxy. Votes by proxy must be in must be returned to us by August 25, 2024. Ballots received after this date and time, duplicate votes and spoiled ballots will not be counted. To participate in the AGM teleconference, please register by August 25, 2024 Registration: https://bit.ly/4aM8IJL Once we have received your response, we will email you the teleconference details and any other necessary documents that will be required for the meeting. Thank you for your participation and if you have any questions, please let me know. Sincerely, Christine White CORD Secretary PROXY-2024Download
Join us and become part of an active Canadian rare disorder community. The only national organization representing all rare disorder patient groups in Canada.
LEARN MORE